Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
4P004 in Knee Synovitis and Osteoarthritis
NCT07225829Phase 2Completed
- Sponsor
- 4Moving Biotech
- Start
- Jun 2025
- Primary completion
- Aug 2026
- Modality
- Peptides
- Countries
- 6
01
Overview
A Phase 2 trial of liraglutide in knee osteoarthritis (OA), knee synovitis, sponsored by 4Moving Biotech. Started Jun 2025; status: completed.
02
Drugs
03
Conditions
knee osteoarthritis (OA)knee synovitis
Beyond the preview
Go deeper on NCT07225829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07225829.